Identification of Genes Predicting Poor Response of Trastuzumab in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer.
Xinrui DongHuijuan DaiAijun SunZhenfeng YuYueyao DuPublished in: Journal of immunology research (2022)
could be used for trastuzumab response prediction and prognostic prediction in HER2+ breast cancer.